PharmaTrends & News
137 views | +0 today
Follow
PharmaTrends & News
What's current and relevant to the pharmacutical drug industry.
Curated by MedSpan
Your new post is loading...
Your new post is loading...
Scooped by MedSpan
Scoop.it!

Medicare's Hospital Readmission Reduction Program - Increasing Penalties, Increasing Pressure

Medicare's Hospital Readmission Reduction Program - Increasing Penalties, Increasing Pressure | PharmaTrends & News | Scoop.it
Medicare's readmissions penalties increases pressure & spurs hospitals to action.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Bayer to test Xarelto in heart attack prevention

FRANKFURT, Nov 13 (Reuters) - German drugmaker Bayer will start the largest drug trial so far involvingblood-thinner Xarelto in a bid to widen its use to become atreatment for preventing repeat heart...
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

UPDATE2: Abbott, Gilead impress with upbeat results for oral hep C drugs - FierceBiotech

UPDATE2: Abbott, Gilead impress with upbeat results for oral hep C drugs - FierceBiotech | PharmaTrends & News | Scoop.it
After impressing analysts with topline results last month, Abbott revealed that its triple-combo of antiviral drugs offered slightly better efficacy when given with ribavirin than without in its Phase IIb "Aviator" study.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Malaria Drug Subsidies: Good Idea Or Wrong Path? : NPR

Malaria Drug Subsidies: Good Idea Or Wrong Path? : NPR | PharmaTrends & News | Scoop.it
A test of subsidies in Africa for the most effective malaria drug treatment is drawing fire. Supporters say the subsidies helped improve access and drive out less effective drugs.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Program Connects Patients With Experimental Drugs

Program Connects Patients With Experimental Drugs | PharmaTrends & News | Scoop.it
FDA's compassionate-use program gives seriously ill people a path to obtain drugs that are still in testing. Chronicling one woman's brush with death.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Manufacturing lapses put drugmakers in unwelcome spotlight - FiercePharma

Manufacturing lapses put drugmakers in unwelcome spotlight - FiercePharma | PharmaTrends & News | Scoop.it
Anyone who follows pharma knows that FDA has called manufacturers on the carpet quite often over the past few years.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Our Mixed Up Views On The Mixed Up Medicines Responsible For Deadly Meningitis - Forbes

Our Mixed Up Views On The Mixed Up Medicines Responsible For Deadly Meningitis - Forbes | PharmaTrends & News | Scoop.it
English: Logo of the . (Photo credit: Wikipedia) The big drug industry news this morning: at least 35 people have gotten fungal meningitis from steroid injections into their spines, and 5 of them are dead.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Nonprescription Medication Abuse More Common Than Perceived

Nonprescription Medication Abuse More Common Than Perceived | PharmaTrends & News | Scoop.it
Nonprescription drugs are just as probable to cause poisoning as prescription drugs, a new study suggests.Published online in Springer's Journal of Medical Toxicology, Timo...
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Higher Hurdles For Clinical Trials Benefit Everyone - Forbes

Higher Hurdles For Clinical Trials Benefit Everyone - Forbes | PharmaTrends & News | Scoop.it
Xalkori There seems to be no shortage these days of people criticizing the biopharmaceutical industry. Certainly, this industry hasn’t behaved with distinction.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

FDA tries to protect public from fake Internet pharmacies - FiercePharma

FDA tries to protect public from fake Internet pharmacies - FiercePharma | PharmaTrends & News | Scoop.it
With more Internet pharmacies showing up than the FDA can possibly police, the agency is trying a new tactic to thwart sales of fake or outdated drugs.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Is big data the next digital disruptor in pharma marketing? | pharmaphorum

Is big data the next digital disruptor in pharma marketing? | pharmaphorum | PharmaTrends & News | Scoop.it
This article is about big data and how it impacts on pharmaceutical marketing.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Drug Utilization Management Trends in ACOs

Drug Utilization Management Trends in ACOs | PharmaTrends & News | Scoop.it
In today's post we share a research study that MedSpan conducted on how Accountable Care Organizations (ACOs) will impact the way drug therapies are prescribed and used. This quantitative study abo...
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics - Forbes

AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics - Forbes | PharmaTrends & News | Scoop.it
The American Medical Association is urging Congress and federal regulators to end the drug industry practice of "pay for delay" which allows brand name pharmaceutical companies to pay generic drug makers to keep cheaper prescriptions off the market.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Drugmakers weather Sandy well; logistics now an issue - FiercePharma

Drugmakers weather Sandy well; logistics now an issue - FiercePharma | PharmaTrends & News | Scoop.it
There may be the calm before the storm but it is chaos and then clean up afterward.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff - Forbes

Sanofi's CEO On The New York Times' Criticism Of Drug Prices And Surviving The Patent Cliff - Forbes | PharmaTrends & News | Scoop.it
Sanofi's chief executive checks in on current events.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

U.S. Concern Over Compounders Predates Meningitis Outbreak

U.S. Concern Over Compounders Predates Meningitis Outbreak | PharmaTrends & News | Scoop.it
When the agency last year suspected sales of a substandard drug and sought samples, a trade group for pharmacists gave instructions on how to sidestep such requests.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Physicians Identify Reasons For High Cost Of Cancer Drugs, Prescribe Solutions

Physicians Identify Reasons For High Cost Of Cancer Drugs, Prescribe Solutions | PharmaTrends & News | Scoop.it
A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentar...
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

In A First, An Experimental Drug May Help Boys With Muscular Dystrophy - Forbes

In A First, An Experimental Drug May Help Boys With Muscular Dystrophy - Forbes | PharmaTrends & News | Scoop.it
Sarepta Therapeutics A new experimental drug appears to improve the muscle function of boys with muscular dystrophy, increasing the distance the boys can walk in six minutes compared to when they began taking it a year before.
more...
No comment yet.
Scooped by MedSpan
Scoop.it!

Big Pharma shuns dirt-cheap cancer drug - FiercePharma

Big Pharma shuns dirt-cheap cancer drug - FiercePharma | PharmaTrends & News | Scoop.it
Patients with Type 2 diabetes taking metformin are less likely to develop some forms of cancer, and that has a lot of folks really excited in drug research. But that feeling doesn't carry over to Big Pharma, which can't see how to make it pay off.
more...
No comment yet.